Adult Growth Hormone Therapy — Prior Authorization (Somatropin, Skytrofa, Sogroya)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Nevada policy alerts
Know when Blue Cross Blue Shield - Nevada releases new policies or updates existing guidance.
Monitor payer policy activity
Prior authorization form and requirements for initiation and reauthorization of somatropin and long-acting growth hormone products for adults (≥18 years), including transition from pediatric therapy and HIV-associated wasting, for members served by Anthem/Blue Cross Blue Shield plans in Indiana.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.